Spots Global Cancer Trial Database for PROSTAC: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Docetaxel or Cabazitaxel.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: PROSTAC: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Docetaxel or Cabazitaxel.
Official Title: Prospective Multi-centre Study of Prognostic Factors in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Docetaxel or Cabazitaxel.
Study ID: NCT02362620
Interventions
Study Description
Brief Summary: PROSTAC is a prospective multicentre observational study in metastatic Castration-Resistant Prostate Cancer (mCRPC), designed to explore prognostic biomarkers in patients undergoing treatment with docetaxel or cabazitaxel
Detailed Description: This study is a prospective biomarker study of patients with mCRPC undergoing treatment with docetaxel or cabazitaxel as standard of care treatment. The participants will undergo serial pre- and post-therapy blood collection for biomarker analysis as part of the primary objective of the study.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Hospital Universitario de Santiago, Santiago de Compostela, A Coruña, Spain
ICO L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain
Hospital Althaia Manresa, Manresa, Barcelona, Spain
Hospital de Especialidades de Jerez de la Frontera, Jerez de la Frontera, Cádiz, Spain
Hospital Costa del Sol, Marbella, Málaga, Spain
Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain
Hospital Universitario de Canarias, La Laguna, Tenerife, Spain
Fundacion Centro Oncologico de Galicia, A Coruna, , Spain
Hospital Universitario Vall D'Hebron, Barcelona, , Spain
Hospital de Ciudad Real, Ciudad Real, , Spain
Hospital Universitario Reina Sofia, Cordoba, , Spain
Hospital Universitario Virgen de las Nieves, Granada, , Spain
Hospital Universitario de Guadalajara, Guadalajara, , Spain
Hospital Universitario Gregorio Maranon, Madrid, , Spain
Coordination PROCURE-Centro Nacional de Investigaciones Oncologicas, Madrid, , Spain
Hospital Universitario Clinico San Carlos, Madrid, , Spain
Hospital Universitario 12 de Octubre, Madrid, , Spain
Centro Integral Oncológico Clara Campal, Madrid, , Spain
Anatomical Pathology PROCURE, Malaga, , Spain
Hospital Regional Universitario Virgen de la Victoria, Malaga, , Spain
Hospital Morales Messeguer, Murcia, , Spain
Hospital Universitario Virgen de la Victoria, Málaga, , Spain
Hospital Son Espases, Palma de Mallorca, , Spain
Complejo Hospitalario de Pontevedra, Pontevedra, , Spain
Hospital Universitario La Fe, Valencia, , Spain
Contact Details
Name: David Olmos, MD, PhD
Affiliation: Head of Prostate Cancer Clinical Research Unit CNIO
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
